LATEST NEWS
- Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology
- New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
- Neuro-Bio’s first paper of 2026 has been published!
- Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures